Point State Capital LP Bluebird Bio, Inc. Transaction History

Point State Capital LP

  • $4.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$26.16 - $63.5 $277,296 - $673,100
-10,600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$46.96 - $61.67 $497,776 - $653,702
10,600 New
10,600 $930,000
Q2 2019

Aug 14, 2019
SELL
$75.84 - $105.21 $310,944 - $431,361
-4,100 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$64.44 - $104.11 $264,204 - $426,851
4,100 New
4,100 $645,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email